China Pharma Holdings (CPHI) Prepaid Assets (2014 - 2026)
China Pharma Holdings (CPHI) reported Prepaid Assets of $74279.0 for Q1 2026, down 9.93% on a YoY basis from $82469.0 in Q1 2025, and down 9.82% quarter-over-quarter from $82368.0 in Q4 2025.
China Pharma Holdings (CPHI) Prepaid Assets (2014 - 2026) Analysis & Trends
China Pharma Holdings has reported Prepaid Assets for 13 years, with the latest figure at $74279.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 9.93% year-over-year to $74279.0; the trailing twelve-month figure through Mar 2026 stood at $74279.0 (down 9.93% YoY), and the FY2025 full-year result was $82368.0, up 1.28% from the prior year.
- Prepaid Assets for Q1 2026 stood at $74279.0, down from $82368.0 in the prior quarter.
- The five-year high for Prepaid Assets was $268498.0 in Q3 2023, with the low at $71788.0 in Q1 2022.
- Historically, Prepaid Assets has averaged $107702.9 across 5 years, with a median of $87269.0 in 2022.
- Annual changes were most pronounced in 2023 — Prepaid Assets surged 207.67% — and 2025, when it plunged 59.57%.
- China Pharma Holdings' Prepaid Assets stood at $77697.0 in 2022, then jumped by 41.91% to $110258.0 in 2023, then slipped by 26.24% to $81328.0 in 2024, then increased by 1.28% to $82368.0 in 2025, then dropped by 9.82% to $74279.0 in 2026.
- The last three Prepaid Assets figures came in at $74279.0 (Q1 2026), $82368.0 (Q4 2025), and $75627.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | China Pharma Holdings | 18.87 Mn | 18.70 Mn | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,279.00 |
| Dec 31, 2025 | 82,368.00 |
| Sep 30, 2025 | 75,627.00 |
| Jun 30, 2025 | 74,869.00 |
| Mar 31, 2025 | 82,469.00 |
| Dec 31, 2024 | 81,328.00 |
| Sep 30, 2024 | 114,202.00 |
| Jun 30, 2024 | 115,610.00 |
| Mar 31, 2024 | 203,999.00 |
| Dec 31, 2023 | 110,258.00 |
| Sep 30, 2023 | 268,498.00 |
| Jun 30, 2023 | 117,979.00 |
| Mar 31, 2023 | 102,774.00 |
| Dec 31, 2022 | 77,697.00 |
| Sep 30, 2022 | 87,269.00 |
| Jun 30, 2022 | 89,935.00 |
| Mar 31, 2022 | 71,788.00 |
| Dec 31, 2021 | 58,792.00 |
| Sep 30, 2021 | 72,805.00 |
| Jun 30, 2021 | 54,034.00 |